SuperworthPetmed Express EPS PETS
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- −$1.38
- Latest quarter, Q1 FY27
- −$0.28
- Fiscal year 2026
- −$2.75
Petmed Express' earnings per share was −$1.38 over the twelve months to Jun 30, 2026.
In its latest quarter, Q1 FY27, it was −$0.28.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2026 | −$2.75 | n/a |
| FY2025 | −$0.30 | n/a |
| FY2024 | −$0.38 | −252% |
| FY2023 | $0.25 | −73% |
| FY2022 | $0.92 | −40% |
| FY2021 | $1.53 | +20% |
| FY2020 | $1.28 | −30% |
| FY2019 | $1.84 | +1% |
| FY2018 | $1.82 | +56% |
| FY2017 | $1.17 | +15% |
| FY2016 | $1.02 | +16% |
| FY2015 | $0.88 | −3% |
| FY2014 | $0.91 | +6% |
| FY2013 | $0.86 | +8% |
| FY2012 | $0.80 | −14% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q1 FY27 | −$0.28 | n/a | −$1.38 | |
| Q4 FY26 | −$0.19 | n/a | −$2.75 | |
| Q3 FY26 | −$0.50 | n/a | −$3.12 | |
| Q2 FY26 | −$0.41 | −473% | −$2.65 | |
| Q1 FY26 | −$1.65 | −1017% | −$2.13 | |
| Q4 FY25 | −$0.56 | n/a | −$0.30 | |
| Q3 FY25 | −$0.03 | n/a | $0.01 | |
| Q2 FY25 | $0.11 | +267% | −$0.06 | |
| Q1 FY25 | $0.18 | n/a | −$0.14 | |
| Q4 FY24 | −$0.25 | n/a | −$0.38 | |
| Q3 FY24 | −$0.10 | n/a | −$0.14 | |
| Q2 FY24 | $0.03 | −79% | −$0.05 |
Against its peers
Companies in Healthcare nearest Petmed Express' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PETSPetmed Express | −$1.38 | |
| NEPHNephros | $0.16 | +33% a year |
| ATNMActinium Pharmaceuticals | $0.36 | |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| SPROSpero Therapeutics | $0.11 | |
| LFVNLifevantage | $0.40 | −46% a year |
| ICCCImmucell | $0.08 | −58% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| PLXProtalix BioTherapeutics | $0.23 | +283% a year |
| NATRNatures Sunshine Products | $1.01 | +36% a year |
| Peer median | $0.38 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Petmed Express
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.